Literature DB >> 20682156

Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction.

Maria José Carvalho Carmona1, Laura Mariana Martins, Matheus Fachini Vane, Breno Altero Longo, Lemuel Silva Paredes, Luiz Marcelo Sá Malbouisson.   

Abstract

BACKGROUND AND OBJECTIVES: Several classes of inotropic drugs with different hemodynamic effects are used in the treatment of low cardiac output in patients with diastolic dysfunction undergoing cardiac surgery. The objective of the present study was to compare the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in this population of patients.
METHODS: After approval by the Ethics Committee of the institution and signing of the informed consent, 20 patients undergoing cardiac surgery with cardiac index < 2 L*min(-1)*m(2) after anesthetic induction and placement of a pulmonary artery catheter were randomly divided to receive dobutamine 5 microg*kg(-1). min(-1) (n = 10), or milrinone 0.5 microg*kg(-1)*min(-1) (n = 10). Hemodynamic parameters were measured after anesthetic induction and after 30 and 60 minutes, and arterial and venous blood gases were measured at baseline and 60 minutes. Non-paired Student t test or two-way ANOVA for repeated measurements was used to compare the data.
RESULTS: Dobutamine and milrinone promoted significant increases in cardiac index (56% and 47%) and oxygen supply (53% and 45%), and reduction in systemic (33% and 36%) and pulmonary (34% and 19%) vascular resistance, respectively. However, statistically significant differences were not observed between both drugs.
CONCLUSIONS: Both inotropic drugs were similarly effective in restoring tissue blood flow and oxygen supply to adequate levels in patients with low cardiac output undergoing cardiac surgery. Copyright 2010 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682156     DOI: 10.1016/S0034-7094(10)70032-5

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  6 in total

1.  Comparison of Levosimendan, Milrinone and Dobutamine in treating Low Cardiac Output Syndrome Following Valve Replacement Surgeries with Cardiopulmonary Bypass.

Authors:  Mohd Yunus; Habib Md Reazaul Karim; Manuj Kumar Saikia; Prithwis Bhattacharyya; Samarjit Dey
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 2.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.

Authors:  Julia Schumann; Eva C Henrich; Hellen Strobl; Roland Prondzinsky; Sophie Weiche; Holger Thiele; Karl Werdan; Stefan Frantz; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

Review 3.  Postoperative Right Ventricular Failure in Cardiac Surgery.

Authors:  Victor H Nieto Estrada; Daniel L Molano Franco; Albert A Valencia Moreno; Jose A Rojas Gambasica; Cristian C Cortes Nunez
Journal:  Cardiol Res       Date:  2016-12-31

4.  Hemodynamic effects of inotropic drugs in heart failure: A network meta-analysis of clinical trials.

Authors:  Ling Long; Hao-Tian Zhao; Li-Min Shen; Cong He; Shan Ren; He-Ling Zhao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Mijoo Kim; Seok-Woo Seong; Pil Sang Song; Jin-Ok Jeong; Jeong Hoon Yang; Hyeon-Cheol Gwon; Young-Guk Ko; Cheol Woong Yu; Woo Jung Chun; Woo Jin Jang; Hyun-Joong Kim; Jang-Whan Bae; Sung Uk Kwon; Hyun-Jong Lee; Wang Soo Lee; Sang-Don Park; Sung Soo Cho; Jae-Hyeong Park
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

6.  Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.

Authors:  Dorthe Viemose Nielsen; Christian Torp-Pedersen; Regitze Kuhr Skals; Thomas A Gerds; Zidryne Karaliunaite; Carl-Johan Jakobsen
Journal:  Crit Care       Date:  2018-02-26       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.